Fabio Gallazzi Selected Research

Fabio Gallazzi Research Topics

Disease

26	Neoplasms (Cancer) 02/2022 - 10/2002
20	Melanoma (Melanoma, Malignant) 02/2022 - 10/2002
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2021 - 04/2017
2	Prostatic Neoplasms (Prostate Cancer) 11/2019 - 09/2011
2	B-Cell Lymphoma (Lymphoma, B Cell) 11/2015 - 11/2003
2	Lymphoma (Lymphomas) 11/2015 - 11/2003
2	Alzheimer Disease (Alzheimer's Disease) 10/2011 - 02/2010
1	Cachexia 05/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	COVID-19 04/2021
1	Severe Acute Respiratory Syndrome 04/2021
1	Pain (Aches) 01/2019
1	Hypoxia (Hypoxemia) 01/2014
1	Amyloid Plaque 10/2011
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2008
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2008
1	Disease Progression 11/2003
1	Leukemia 11/2003

Drug/Important Bio-Agent (IBA)

22	Peptides (Polypeptides)IBA 05/2022 - 10/2002
15	alpha-MSHIBA 02/2022 - 10/2002
12	Type 1 Melanocortin ReceptorIBA 02/2022 - 05/2009
8	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 02/2022 - 11/2007
8	LactamsIBA 01/2017 - 02/2008
7	Melanocyte-Stimulating Hormones (MSH)IBA 01/2020 - 08/2009
6	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2021 - 07/2010
5	Chelating AgentsIBA 01/2017 - 11/2003
4	AcidsIBA 02/2022 - 04/2011
4	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020 - 02/2018
4	Amino Acids FDA Link 11/2015 - 10/2002
4	N-glycylglutamic acidIBA 06/2012 - 02/2008
3	LigandsIBA 11/2019 - 01/2015
3	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2019 - 06/2012
3	Messenger RNA (mRNA)IBA 11/2015 - 11/2002
2	MelanocortinsIBA 05/2022 - 10/2012
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2011
2	MetalsIBA 03/2021 - 05/2009
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2016 - 03/2008
2	lysinenorleucineIBA 06/2012 - 11/2009
2	tryptophylglycineIBA 06/2012 - 11/2009
2	arginylprolineIBA 06/2012 - 11/2009
2	Lysine (L-Lysine)FDA Link 11/2007 - 10/2002
1	Pharmaceutical PreparationsIBA 05/2022
1	AlbuminsIBA 02/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	IntegrinsIBA 01/2022
1	Integrin alpha4beta1 (VLA-4)IBA 01/2022
1	PeptidomimeticsIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 04/2021
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2020
1	Biological ProductsIBA 01/2020
1	Lutetium-177IBA 01/2020
1	Cyclic PeptidesIBA 01/2020
1	AntigensIBA 11/2019
1	Coloring Agents (Dyes)IBA 11/2019
1	Opioid Receptors (Opioid Receptor)IBA 01/2019
1	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 01/2019
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 02/2018
1	cyanine dye 5IBA 02/2018
1	hexanoic acid (hexanoate)IBA 01/2017
1	Aminocaproic Acid (6 Aminocaproic Acid)FDA LinkGeneric 01/2017
1	CopperIBA 11/2015
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2015
1	Tyr(3)- octreotateIBA 11/2015
1	EDDA (NiEDDA)IBA 01/2015
1	tricineIBA 01/2015
1	Oxygen (Dioxygen)IBA 01/2014
1	1,2,4-benzotriazine 1,4-di-N-oxideIBA 01/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2014
1	Antineoplastic Agents (Antineoplastics)IBA 01/2014
1	dioxotechnetiumIBA 01/2014
1	Copper-62IBA 10/2012
1	triazacyclononaneIBA 06/2012
1	Amyloid (Amyloid Fibrils)IBA 10/2011
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2011
1	Radioisotopes (Radionuclides)IBA 04/2011
1	Octreotide (Sandostatin)FDA LinkGeneric 07/2010
1	Amyloid beta-PeptidesIBA 02/2010
1	arginyl-glycyl-aspartic acidIBA 08/2009
1	N- (2- amino- 3- (4- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N',N',N'',N''- pentaacetic acidIBA 05/2009
1	N- (2- aminoethyl)- 1,2- diaminocyclohexane- N,N',N''- pentaacetic acid-Re(Cys(3,4,10))-Phe(7)-Arg(11)- alpha-MSH(3-13)IBA 05/2009
1	Bombesin Receptors (Bombesin Receptor)IBA 10/2008
1	BombesinIBA 10/2008
1	RheniumIBA 11/2007
1	1,4,7,10-tetraazacyclododecane 1,4,7,10-tetraacetic acid (ReO- acetyl(Cys(3,4,10),Phe(7),Arg(7))alpha- MSH(3- 13))IBA 01/2007
1	Codon (Codons)IBA 11/2003
1	Peptide Nucleic AcidsIBA 11/2003

Therapy/Procedure

8	Therapeutics 01/2022 - 10/2002
4	Radiotherapy 01/2020 - 10/2002
1	Precision Medicine 01/2022
1	Computer-Assisted Surgery (Image Guided Surgery) 02/2018
1	Drug Therapy (Chemotherapy) 11/2003